| Pfizer AG - Toviaz, Retardtabletten 4 mg | | 58743 | | 01 | | Toviaz, Retardtabletten 4 mg | | | | G04BD11 | | Fesoterodine | | 18.12.2008 | | |
| | Composition | | fesoterodini fumaras 4.0 mg corresp. fesoterodinum 3.1 mg, xylitolum, lactosum monohydricum 91.1 mg, cellulosum microcristallinum, hypromellosum, glyceroli dibehenas, talcum, poly(alcohol vinylicus), macrogolum 3350, talcum, lecithinum ex soja, E 171, E 132, pro compresso. | | Packungsbestandteile | | Active Agent | Dose |
|---|
| Fesoterodini Fumaras | 4 mg correspond Fesoterodinum 3.1 mg |
| | BAG: Active Agent | Dose |
|---|
| Fesoterodini Fumaras | 4 mg |
| | Inactive agents | Dose | additional_information |
|---|
| Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | Glyceroli Dibehenas | | | | Hypromellosum | | | | Lactose Monohydrate | 91.1 mg | | | Lecithinum ex Soja | | | | Macrogol | 3350 | | | Poly(Alcohol Vinylicus) | | | | Pro Compresso | | | | Talcum | | | | Xylitol | | |
| |
| |
|
